Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A

Project Information

HemAcure

Grant agreement ID: 667421

DOI 10.3030/667421

Project closed

EC signature date 9 December 2015

Start date 1 November 2015

End date 31 October 2018

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 564 395,00

EU contribution € 5 564 395,00

Coordinated by

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Germany